2020-09-04T22:30:02+00:00

Sputnik-V Covid-19 vaccine trial shows 'encouraging' results

The "Sputnik-V" Covid-19 vaccine produced a neutralising antibody response in all 76 participants, according to data published Friday in the medical journal The Lancet. The vaccine often caused mild side effects such as fever.

Experts have claimed the sample size of the Russian study was small and urged for more research on the elderly.

The Brazilian institute Tecpar announced plans to conduct the phase III trials on 10,000 volunteers at the start of next year.

Sources: Content Sources

Source: Deutsche Welle

Source: thelancet.com

Image Source

SputnikVaccine.com

Pentributor:

Érico Andrei

@ericof

Co-founder of Pendect, passionate about open source and knowledge sharing. Made in Mooca.

Card reviewed by: @christoph

Categorization: Locations & Places

Russia

Organizations & Institutions

Cookies🍪

Our website uses scripts, such as cookies, to technically provide the site ("essential scripts") and third-party website tracking technologies to provide and continually improve our services and display advertisements based on the perceived interests of users. By clicking the "Accept All" button, the website visitor agrees to the activation of all scripts. Essential cookies are also executed without the consent. The consent can be revoked or changed at any time with effect for the future. By clicking the "Reject" button, only essential cookies are used. In our data protection policy, we provide detailed information about the type and scope of data processing.

Accept All Reject